HRSA Threatens to Sanction J&J Absent Withdrawal of 340B Rebate Plan
By EsqSocial Corporation 02/10/24
On September 17, the Health Resources and Services Administration (HRSA), which administers the prescription drug discount program established under Section 340B of the federal Public Health Service Act, sent a letter to pharmaceutical manufacturer Johnson & Johnson (J&J), threatening to impose sanctions unless J&J ceases implementation of its recently announced plan to stop offering 340B discounts to disproportionate share hospitals at the time of purchase on two of its drugs and to instead...
By: Manatt, Phelps & Phillips, LLP